TrialHaematologica2025

Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group AALL1331 trial.

Laura E Hogan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.